A clinical feature of metastatic human epidermal growth factor receptor 2-positive (HER2-positive) breast cancer (BC), irrespective of the estrogen receptor (ER) status, is a predilection for the central nervous system (CNS).1 This evidence concerns the gene ERBB2 and breast cancer.